Corrigendum: IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation. Biomol Biomed [Internet]. 2023May1 [cited 2023May29];23(3):545. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8739